Navigation Links
Substandard and counterfeit antimalarial drugs discovered in Ghana
Date:11/8/2010

Rockville, Md., November 8, 2010 Substandard and counterfeit versions of thirteen key antimalarial medicines were uncovered in multiple locations across Ghana by the Medicines Quality Monitoring surveillance program. Set up by the Ghana Food and Drugs Board (FDB) in collaboration with the U.S. Pharmacopeial Convention (USP) and the U.S. Agency for International Development (USAID), the program samples antimalarials across the public and private sectors. It was established in 2008 and is implemented by USP's Promoting the Quality of Medicines (PQM) initiative. USP is a scientific nonprofit organization that develops globally recognized standards for the quality of medicines. Through the PQM program, USP works in developing countries to help verify and improve the quality of medications intended to treat life-threatening neglected diseases such as malaria, HIV/AIDS and tuberculosis.

"Few people fully realize the devastation that distribution of substandard or counterfeit medications can wreak on vulnerable populations," said Stephen Opuni, M.D., chief executive officer of the FDB. "In this case some of the drugs discovered contained no active pharmaceutical ingredient, while others failed to meet required quality standards. This causes great harm in two ways: the individual patients taking the drugs get no relief, and drug-resistant strains of malaria may grow stronger. In addition, people lose confidence in the efficacy of medicines and may be reluctant to seek medical help when they need it. I'm very pleased with the outcomes we're seeing from the Medicines Quality Monitoring program."

In 2009 the same program uncovered a counterfeit version of Novartis' Coartem, another widely used antimalarial. In that case an alert citizen notified the authorities after suspecting the drug he bought might be fake. "Last year's seizure of counterfeit drugs showed the importance of public education," said Patrick Lukulay, Ph.D., director of the PQM program. "In the current case, rigorous surveillance worked very well. The fact that the fake and poor quality drugs were so widespreadfound in many areas across Ghana, and in many types of outletsunderscores the need not only for continuing surveillance but also for active enforcement of anti-counterfeiting laws."

The discovery of the counterfeitstragically, in use at a government-run hospital and private clinic, and being distributed through many pharmacieshas resulted in a nationwide recall of all thirteen drugs, including publicizing the names of the outlets where they were found. This is intended as a strong deterrent, making pharmacy and hospital procurement personnel more vigilant about their suppliers. Manufacturers of some of the recalled medications will be required to meet with the FDB for required regulatory sanctions. Noted Dr. Lukulay, "It's important to keep in mind that all these fake and substandard medicines were found just in one round of post-market surveillance, just of antimalarials. The existence of many more substandard and counterfeit medications for other types of medicines and in other locations and facilities must be assumed. Public education and official collaborations between public and private sectors are both essential to protecting public health here in Ghana and in many other developing nations."


'/>"/>

Contact: Laura Provan
lnp@usp.org
301-816-8268
US Pharmacopeia
Source:Eurekalert

Related medicine news :

1. Cambodia takes action in fight against substandard and counterfeit medicines
2. One-third of antimalarial medicines sampled in 3 African nations found to be substandard
3. MSU launches first anti-counterfeiting research program
4. Pricey Drugs May Not Mean Better Care
5. MIT chemists engineer plants to produce new drugs
6. Diabetes Drugs Might Lower Risk of Lung Cancer
7. Eliminating or reducing cost-sharing for high-value prescription drugs improves medication use
8. Use Anemia Drugs for Cancer Patients With Caution, Experts Say
9. FDA Calls for New Warnings on Some Prostate Cancer Drugs
10. FDA Advisers Back Anemia Drugs for Kidney Patients
11. Penn study gives hope for new class of Alzheimers disease drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... Michael Vick ... and transforming the quarterback position. The former overall number one pick in the 2001 ... football career. He holds the record for the most career rushing yards by a ...
(Date:4/24/2017)... ... April 24, 2017 , ... The bar for just about everything—apparel, eyewear, cars ... rarified air of pop and film stardom.(1) Not to be left out is that ... Grins now run the gamut from being encrusted with jewels and precious metals to, ...
(Date:4/24/2017)... ... ... The John P. McGovern Museum of Health and Medical Science is now ... health, and share results with their physicians. Members and guests can sign up for ... BrainCheck founder, Dr. David Eagleman, formerly at Baylor College of Medicine and now at ...
(Date:4/24/2017)... TEXAS (PRWEB) , ... April 24, 2017 , ... ... (SaaS) based healthcare compliance and credentialing solutions, today announced that Kyle Allain has ... leads symplr’s Cactus Provider Management sales and operations, including provider, payor and managed ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... health of individuals with HIV because it is not known to have significant ... have favorable effects to both lower cholesterol levels and dampen inflammation in the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Companion animal ... in pets such as canine, avian and feline. ... types such as Attenuated Live Vaccines, Conjugate Vaccines, ... and Recombinant Vaccines. Attenuated live vaccines are derived ... which have been weakend under laboratory conditions. Conjugate ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, ... on providing the Urology, Uro/Gyn and Gynecology markets with ... the first quarter ended March 31, 2017 after the ... The Company will host a conference call and ... on Tuesday, May 2, 2017 at 4:30 p.m. Eastern ...
(Date:4/18/2017)... , April 18, 2017  Socionext Inc. ... collaboration started in 2016, in which Socionext extracts ... SOINN". The companies achieved initial results in reading ... by Artificial Brain SOINN. The results will be ... Sight, April 19-21, at booths 4505 & 4507. ...
Breaking Medicine Technology: